RAIPUR: The annual Chhattisgarh Cancer Conclave held at the Balco Medical Centre (BMC) in Nava Raipur featured live surgical ...
The committee recommended Keytruda's subcutaneous form for all indications and as neoadjuvant/adjuvant treatment in PD-L1-positive head and neck cancer.
The FDA has granted fast track designation to the antibody-drug conjugate (ADC) CRB-701 for the treatment of recurrent or ...
The FDA has granted fast track designation to the investigational drug CRB-701 for recurrent or metastatic head and neck ...
Completing treatment for head and neck cancer is a milestone, but recovery is an ongoing journey. With follow-ups, ...
The firm said that it has been awarded funding to support the development of its cancer detection technology and a test for oropharyngeal squamous cell carcinoma.